HeartBeam Provides Update on Regulatory Path Following FDA Decision on 12-Lead ECG Synthesis Software Application - Reportify

HeartBeam Provides Update on Regulatory Path Following FDA Decision on 12-Lead ECG Synthesis Software Application

HeartBeam(US:BEAT) Businesswire·2025-11-27 05:32

公司动态 - HeartBeam公司就其12导联心电图合成软件应用的监管路径提供了最新进展该更新是在美国食品药品监督管理局就该应用做出决定之后发布的 [1]